about
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Discovery and Pharmacological Characterisation of a Novel Series of Highly Selective Inhibitors of Cyclin-Dependent Kinases 4 and 6 as Anticancer Agents.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Unveiling new chemical scaffolds as Mnk inhibitors.
@en
type
label
Unveiling new chemical scaffolds as Mnk inhibitors.
@en
prefLabel
Unveiling new chemical scaffolds as Mnk inhibitors.
@en
P2093
P2860
P50
P356
P1476
Unveiling new chemical scaffolds as Mnk inhibitors
@en
P2093
Jingfeng Lu
Sarah Diab
Shudong Wang
Sunita K C Basnet
P2860
P304
P356
10.4155/FMC.15.190
P577
2016-02-24T00:00:00Z